Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2026-01-28 @ 4:47 PM
Study NCT ID:
NCT05770102
Status:
RECRUITING
Last Update Posted:
2025-11-24
First Post:
2023-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
Sponsor:
Cancer Research UK
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Malignancy | View |
| None | Malignant Neoplasm | View |
| None | Lymphoproliferative Disorders | View |
| None | Neoplasms by Histologic Type | View |
| None | Neoplasms by Site | View |
| None | Cancer | View |
| None | Colorectal Neoplasms | View |
| None | Endometrial Neoplasms | View |
| None | Melanoma | View |
| None | Solid Tumours | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Adult | View |
| None | Antineoplastic Agents | View |
| None | Atezolizumab | View |
| None | Cancer | View |
| None | Child | View |
| None | Malignancy | View |
| None | Malignant Neoplasms | View |
| None | Molecular Targeted Therapy | View |
| None | Neoplasms by Histologic Type | View |
| None | Neoplasms by Site | View |
| None | Paediatric | View |
| None | Precision Medicine | View |
| None | Rare | View |
| None | Tumour-agnostic | View |
| None | Young adult | View |